
STAT+: Pharmalittle: We’re reading about chemo drugs failing quality tests, Gavi losing U.S. funding, and more
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, a welcome change after the unusually steamy heat of the past few days. This gives us hope that we can focus more readily on the …